CD4 and neoplasm: There was a notable increase in tumor-infiltrating CD3+ T cells, CD4+ T cells and CD8+ T cells (Figure 3B–D and Supplementary Figure S1), indicating that mIL12 treatment significantly promotes T lymphocyte infiltration.